β Home
βΉοΈ Info
π§Ύ Overview π Core Facts π₯ Video Insights β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π’ Company Q&A π οΈ Industry Q&A π Competitors π Stock Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risks π§© Segmentationπ§ Tools
β Due DiligenceKey Metrics
Pay attention and research significant changes from year to year values. [ ! ]
Fixed Column | Revenue Per Share | Net Income Per Share | Operating Cash Flow Per Share | Free Cash Flow PerShare | Cash Per Share | Book Value Per Share | Tangible Book Value Per Share | Shareholders Equity Per Share | Interest Debt Per Share | Market Cap | Enterprise Value | P/E Ratio | Price To Sales Ratio | POCF ratio | PFCF Ratio | P/B Ratio | PTB Ratio | EV To Sales | Enterprise Value Over EBITDA | EV To Operating Cash Flow | EV To Free Cash Flow | Earnings Yield | Free Cash Flow Yield | Debt To Equity | Debt To Assets | Net Debt To EBITDA | Current Ratio | Interest Coverage | Income Quality | Dividend Yield | Payout Ratio | Sales General And Administrative To Revenue | R&D To Revenue | Intangibles To Total Assets | CAPEX To Operating Cash Flow | CAPEX To Revenue | CAPEX To Depreciation | Stock Based Compensation To Revenue | Graham Number | ROIC | Return On Tangible Assets | Graham Net-Net | Working Capital | Tangible Asset Value | Net Current Asset Value | Invested Capital | Average Receivables | Average Payables | Average Inventory | Days Sales Outstanding | Days Payables Outstanding | Days Of Inventory On Hand | Receivables Turnover | Payables Turnover | Inventory Turnover | ROE | CAPEX Per Share |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-12 | 25.71 | 5.93 | 8.76 | 6.86 | 6.64 | 21.93 | -3.75 | 21.89 | 16.04 | 196503581552 | 216302581552 | 16.46 | 3.8 | 11.15 | 14.23 | 4.46 | 4.46 | 4.18 | 10.44 | 12.28 | 15.67 | 0.06 | 0.07 | 0.71 | 0.31 | 0.96 | 1.04 | 14.46 | 1.48 | 0.04 | 0.64 | 0 | 0.19 | 0.51 | 0.22 | 0.07 | 0.63 | 0.02 | 54.07 | 0.16 | 0.24 | -17.27 | 1012000000 | -7545000000 | -28416000000 | 63556000000 | 9457500000 | 4749000000 | 5818000000 | 67.32 | 130.1 | 162.85 | 5.42 | 2.81 | 2.24 | 0.27 | 1.9 |
2023-12 | 22.33 | 7.11 | 6.92 | 5.6 | 6.68 | 22.37 | 0.89 | 22.33 | 13.02 | 210931393623.38 | 223886393623.38 | 14.2 | 4.52 | 14.59 | 18.02 | 4.52 | 4.52 | 4.8 | 12.26 | 15.49 | 19.13 | 0.07 | 0.06 | 0.56 | 0.26 | 0.71 | 1.16 | 11.43 | 1.69 | 0.03 | 0.49 | 0 | 0.24 | 0.45 | 0.19 | 0.06 | 0.33 | 0.02 | 59.75 | 0.11 | 0.27 | -13.99 | 4091000000 | 1859000000 | -22714000000 | 59906000000 | 9635000000 | 5036000000 | 6544000000 | 73.34 | 144.16 | 173.05 | 4.98 | 2.53 | 2.11 | 0.32 | 1.32 |
2022-12 | 23.76 | 3.19 | 6.53 | 5.3 | 8.68 | 27.24 | -0.7 | 27.21 | 13.2 | 197166108691.11 | 217613108691.11 | 28.35 | 3.8 | 13.85 | 17.05 | 3.32 | 3.32 | 4.2 | 14.82 | 15.29 | 18.82 | 0.04 | 0.06 | 0.47 | 0.24 | 1.39 | 1.29 | 10.99 | 2.05 | 0.04 | 1.08 | 0 | 0.19 | 0.52 | 0.19 | 0.05 | 0.37 | 0.02 | 44.18 | 0.08 | 0.12 | -12.88 | 8254000000 | -1522000000 | -21120000000 | 81394000000 | 9088500000 | 5349500000 | 6920500000 | 69.68 | 121.29 | 169.11 | 5.24 | 3.01 | 2.16 | 0.12 | 1.22 |
2021-12 | 23.58 | 10.71 | 6.72 | 5.4 | 12.63 | 30.24 | 1.8 | 30.17 | 14.23 | 197337483898.83 | 216023483898.83 | 8.22 | 3.73 | 13.09 | 16.31 | 2.92 | 2.92 | 4.09 | 6.99 | 14.33 | 17.85 | 0.12 | 0.06 | 0.46 | 0.24 | 0.6 | 1.51 | 33.23 | 0.63 | 0.04 | 0.31 | 0 | 0.18 | 0.48 | 0.2 | 0.06 | 0.49 | 0.01 | 85.27 | 0.23 | 0.35 | -11.64 | 15510000000 | 4045000000 | -18255000000 | 92393000000 | 9159500000 | 5478000000 | 6898500000 | 57.18 | 127.74 | 153.34 | 6.38 | 2.86 | 2.38 | 0.36 | 1.32 |
2020-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2019-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2018-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2017-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2016-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2015-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2014-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |

π Explore more key metrics for Novartis!
Sign up for free or log inπ Your free copy of "The Checklist Value Investor β A Smarter Way to Pick Stocks" is waiting